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E J C S U P P L E M E N T S 4 ( 2 0 0 6 ) 2 7 –5 3 47sion varies depending on the histological type of NSCLC. Identifi-
cation of tumor immunophenotype makes possible to obtain
more data about metastasis potential, malignancy rate and prog-
nosis. This molecular markers panel can be used for early detec-
tion of LC recurring and metastasis.
doi:10.1016/j.ejcsup.2006.04.114
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Background: While in cancer from colon and ovary number and
reactivity of tumor infiltrating lymphocytes (TILs) were associated
with survival, in NSCLC, the clinical significance of TILs is
unknown. While TILs demonstrated antigen specific Interferon
(IFN)-c secretion and cytotoxicity in vitro, their in situ activation
status remains difficult to determine. Here, we examine molecu-
lar assessment of CD8+ T cell reactivity in NSCLC.
Methods: We determined CD8+ T cell counts in 19 patients with
NSCLC by immunohisto-chemistry and assessed T-cell immune
reactivity by measuring mRNA IFN-c levels by quantitative RT-
PCR (TaqMan) from corresponding tissue. CD8+ T cells were clas-
sified into two groups: Intra-tumoral (distributed in cancer cell
nests and stroma) and peri-tumoral (presented along the invasive
margin). Five hpf were evaluated per each localization (IT and PT,
respectively). Distribution of CD8+ T cells was semi-quantitatively
classified into: 0-none or mild; I-moderate; II-severe. The relation-
ship between the median CD8+ T cell density/hpf and the CD8-
normalized IFN-c mRNA expression was tested (Spearman’s
correlation).
Results: Semi-quantitative analysis revealed significantly higher
CD8+ T cell counts within the tumor compared to the invasive
margin (p < 0.001). However, immune activation status of TILs
represented as IFN-c/CD8 ratio was higher in the peri-tumoral
than in the intra-tumoral compartments (p = .022).
Conclusion: In human NSCLC, IFN-c reactivity of CD8+ T cells is
mostly attributed to the tumor–host interface and indicates an
inadequate activation of TILs within the tumor. This methodology
can be applied to a variety of experimental trials if tumor tissue is
available.
doi:10.1016/j.ejcsup.2006.04.115
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of Cologne, Germany.Background: Cyclooxygenase-2 (COX-2) mRNA expression is
known to be progressively increased in the metaplasia–dyspla-
sia–adenocarcinoma (MDA) sequence of Barrett’s cancer (BC)
development. Much less however, is known about COX-2 mRNA
expression in patients with gastroesophageal reflux disease
(GERD).
Methods: Endoscopic biopsies from 3 patient groups were ana-
lyzed: 43 patients undergoing evaluation for GERD (20 GERD posi-
tive/23 GERD negative) by 24-h pH-monitoring, 20 patients with
Barrett’s esophagus (BE) without dysplasia and 47 with BC. COX-
2 mRNA expression was determined by quantitative real-time
RT-PCR (TaqManTM) assays. The Demeester composite score
(DS > 14.72) was used to match COX-2 mRNA expression levels
with the degree of acid exposure.
Results: Median COX-2 mRNA expression was significantly
upregulated in Barrett’s metaplastic epithelium compared to
matched normal squamous epithelium (NE) in the BE (p = 0.03)
and BC group (p = 0.001). COX-2 mRNA expression levels in NE
did not differ significantly between the 3 study groups however,
within the group of patients evaluated for GERD, specimens
obtained from patients with a mean Deemester score >14.72
showed significantly upregulated COX-2 mRNA levels in the distal
acid-exposed esophagus (p = 0.01).
Conclusion: Our findings suggest that the induction of increased
COX-2 mRNA expression occurs already in GERD without the
presence of Barrett’s metaplasia. A field effect as shown for other
genes could not be detected for COX-2 expression in squamous
epithelium in GERD positive, BE or BC patient groups. Chemopre-
vention strategies using selective or non-selective COX-2 inhibi-
tors might be useful in patients with GERD to potentially
prevent the development of Barrett’s metaplasia.
doi:10.1016/j.ejcsup.2006.04.116
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Background: Epidemiological data assume a reduction of risk for
developing an adenocarcinoma of the esophagus for individuals
taking non-steroidal anti-inflammatory drugs. One of the inhib-
ited enzymes, cyclooxygenase-2, is supposed to be involved in
the pathogenesis of Barrett’s cancer. We examined a possible
association between COX-2 protein expression and the progres-
sion of Barrett’s sequence and the type and degree of the environ-
mental inflammatory reaction.
Methods: Squamous epithelium, metaplastic, low-grade and
high-grade dysplastic lesions and tumor tissue of 49 resection
specimens from patients with Barrett’s adenocarcinoma were
analyzed. Immunohistochemical staining was performed with a
48 E J C S U P P L E M E N T S 4 ( 2 0 0 6 ) 2 7 –5 3monoclonal anti-COX-2-antibody, active and chronic inflamma-
tory reactions were classified according to the Updated-Sydney-
System.
Results: Within Barrett’s sequence, a significant progressive
increase in COX-2 expression was identified (p < 0.0001). The most
significant differences were detected between squamous epithe-
lium and Barrett’s metaplasia (p < 0.001) and from low- to high-
grade dysplasia (p < 0.0001). Active and chronic inflammation
were significantly different between squamous epithelium and
Barrett’s metaplasia (p < 0.0001) but not during further progres-
sion in the MDC sequence.
Conclusion: There is a significant association between increas-
ing COX-2 protein levels and the development and progression
of Barrett’s MDC sequence. Increasing COX-2 expression is associ-
ated with a change in type or degree of the associated morpholog-
ical inflammation in Barrett’s metaplasia but not during
progression of MDC. Chemoprevention strategies aiming at a
reduction of COX-2 expression can likely not be monitored by
morphological analysis of the inflammatory reaction.
doi:10.1016/j.ejcsup.2006.04.117
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Background: Hypoxia-inducible factor-1a (HIF-1a) expression
was reported to be associated with tumor growth, progression
and resistance to radio- and chemotherapy. We analyzed if
HIF-1a mRNA or protein expression is associated with histo-
morphologic response or prognosis following neoadjuvant
chemoradiation and surgery in locally advanced esophageal
cancers.
Methods: Fifty-three patients with resectable, locally advanced
esophageal cancers (cT2-4, Nx, M0) received neoadjuvant chemo-
radiation (cisplatin, 5-FU, 36 Gy) followed by transthoracic en bloc
esophagectomy. RNA was isolated from endoscopic biopsies
(paired tumor and normal tissue) prior to neoadjuvant treatment
and quantitative real-time reverse transcriptase PCR (RT-PCR,
TaqManTM) assays were performed to determine HIF-1a mRNA
expression. HIF-1a protein expression in pretreatment biopsies
and posttherapeutic resection specimens was analyzed by immu-
nostaining of tumor cells.
Results: In squamous cell cancer, HIF-1a mRNA expression was
significantly higher in tumor tissue as in paired normal epithe-
lium (Wilcoxon test: p < 0.001). Normal squamous epithelium
showed significant elevated expression in adenocarcinomas sug-
gesting a field effect (Mann–Whitney test: p < 0.04). HIF-1a pro-
tein expression showed a significant downregulation after
chemoradiation.Conclusion: However, neither HIF-1a mRNA nor protein expres-
sion was associated with histomorphologic regression or progno-
sis following neoadjuvant chemoradiation and surgery in locally
advanced esophageal cancers. HIF-1a mRNA expression is differ-
entially upregulated in esophageal squamous cell cancer com-
pared to adenocarcinomas however does not predict tumor
regression or prognosis.
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Background: Reliable quantification of gene expression offers
the possibility of more accurate and prognostically relevant char-
acterization of tissues than potentially subjective interpretations
of histopathologists. The aim of this study was to evaluate the
feasibility of molecular characterization of normal and pathologic
esophageal epithelia. Therefore we measured the expression of
18 selected genes and compared them to histological features in
a spectrum of esophageal disease.
Methods: Esophageal tissue biopsies from patients with foregut
symptoms were laser-capture microdissected and the expression
levels of 18 selected genes were measured by QRT-PCR (Taqman).
Linear discriminant analysis, which uses combinations of genes
to distinguish between histological groups, was performed to
compare gene expression and the following 5 histological groups:
(1) normal squamous epithelium, (n = 32); (2) reflux-esophagitis,
(n = 13); (3) non-dysplastic Barrett’s, (n = 17); (4) dysplastic Bar-
rett’s, (n = 10); (5) adenocarcinoma, (n = 22).
Results: A panel of 7 genes had 90–94% predictive power to dis-
tinguish non-dysplastic and dysplastic Barrett’s esophagus. Clus-
tering analysis revealed structure in gene expression values even
in the absence of histology. Expression levels in 17 genes dif-
fered significantly across histological groups. Classification
based on gene expression agreed with histopathological assess-
ment in the following percentage of cases: normal squamous
epithelium = 53%, reflux-esophagitis = 31%, non-dysplastic Bar-
rett’s = 76%, dysplastic Barrett’s=40% and adenocarcinoma = 59%.
Interestingly, predictive power improved markedly when inflam-
matory and dysplastic tissues were removed (77–94%).
Conclusion: Gene expression classification agrees well with his-
topathological examination. When differences occur, it is unclear
whether this effect is due to intra-observer variability in patho-
logical diagnosis or to a genuine difference between gene expres-
sion and histopathology.
doi:10.1016/j.ejcsup.2006.04.119
